“…In the selected articles, most were published in Italy, ( 3 – 6 , 10 , 12 , 18 , 19 ) i.e , 39% (n=7), followed by Brazil, ( 14 , 17 ) with 11% (n=2), and the United States ( 1 ) (n=1), Sweden ( 11 ) (n=1), Turkey ( 2 ) (n=1), Greece ( 13 ) (n=1), Israel ( 15 ) (n=1), Belgium ( 16 ) (n=1), Germany ( 8 ) (n=1), Korea ( 6 ) (n=1), and Switzerland ( 9 ) (n=1), accounting altogether for 50% (n=9) of articles. Based on this evidence, there is no effect of geographies or economies on patients affected by AARONJ.…”